Harry Glorikian
The Harry Glorikian Show
Good podcast? Give it some love!
Harry Glorikian
The Harry Glorikian ShowEpisodes
Harry Glorikian
The Harry Glorikian Show
Good podcast? Give it some love!
Rate Podcast
Episodes of The Harry Glorikian Show
Mark All
Search Episodes...
Harry's guest this week is Raffi Krikorian, chief technology officer and managing director at Emerson Collective, the social change organization founded by Laurene Powell Jobs. Krikorian is the former vice president of engineering at Twitter (n
Generative AI is going to change how we do things across the entire economy, including the fields Harry covers on the show, namely healthcare delivery, drug discovery, and drug development. But we’re still just starting to figure out exactly ho
If you learned that radiologists looking at CT scans for the traditional signs of coronary artery disease catch only 20 percent of the people who actually have a high risk of a heart attack, and if you learned that there’s a new AI-based test t
Investors and companies in the life science industry have been betting a lot of money over the last few years on a single idea: that computation will help us get a lot better at developing new drugs. But the word “computation” covers a pretty b
If you look back at all the health-tech and drug development companies Harry has hosted on the show, an interesting pattern starts to emerge: a very large number of those companies have gone on to enormous growth and success in their markets. I
One of the most amazing successes in the battle against cancer over the last two decades has been the introduction of antibody drugs that harness the body’s own immune system to kill tumor cells. Finding those drugs may sound like a biology pro
The combination of better data and more powerful computing is helping researchers reinvent the process of discovering new drugs. Within 5-10 years, we’ll likely see a huge wave of new medicines that were either discovered or designed using AI—d
There are about 30 trillion human cells in your body, but there are about 38 trillion bacterial cells, mostly hanging out in your large intestine. And that’s not even counting all the viruses, fungi, protists, and other microbial cells that liv
Quality control is one of those things that only a select few people pay attention to—until something goes wrong, then everyone cares. That's especially true in the drug manufacturing industry, where episodes like cross-contamination in a drug
There’s a lot of talk out there about how artificial intelligence will change the way doctors and nurses take care of patients; you hear some of it right here on this show. But all of that still feels like a forecast rather than a present reali
There’s a good chance that we’re all going to live a lot longer than we think. Or at least, that’s what Harry's guest Sergey Young argues in his book The Science and Technology of Growing Young. Young is an investor who leads a $100 million ven
It's practically the theme of our show that AI is going to change almost everything about the way drugs get developed and the way healthcare gets delivered. But there’s probably nobody better placed to see how this transformation is already hap
Building any kind of startup is hard. Starting a business in healthcare or medical technology is even more challenging, given the long timelines for product development and all the regulatory requirements companies have to meet. But imagine how
If you’re looking for help thinking about the implications of exponential change in all areas of technology, one of the best people you can turn to is Azeem Azhar. He's a writer, entrepreneur, and investor who publishes the incredibly popular a
It’s been less than a year since OpenAI opened up ChatGPT to the general public, and less than six months since OpenAI introduced GPT-4, the large language model that currently powers ChatGPT. But in that brief time, the new crop of generative
Harry's guest this week is Joe DeVivo, the new CEO of Butterfly Network. The company's goal is to make it radically easier for doctors or medical technicians to perform an ultrasound exam on any part of the body, and radically cheaper for a pat
This week Harry's guest is....Harry! We're flipping the script and giving Harry a chance to wax eloquent about AI in healthcare and drug research, the growing role of personal health monitoring devices, the unique features of the Boston life sc
Harry's guest this week is Dr. Isaac Kohane, chair of the Department of Biomedical Informatics at Harvard Medical School and co-author of the new book The AI Revolution in Medicine: GPT-4 and Beyond. Large language models such as GPT-4 are obvi
In the same way that written English is built around an alphabet of just 26 letters, all life on Earth is built around a standard set of just 20 amino acids, which are the building blocks of all proteins. And just as we've invented special char
Owning a dog can be a joy, but one sad downside is that dogs are highly prone to cancer—six million of them are diagnosed with the disease in the U.S. each year. Harry's guest this week, Christina Lopes, is co-founder and CEO of a company calle
Unlike cancer, brain diseases like epilepsy, Alzheimer’s disease, or depression don't tend to have easily measured biomarkers that could help doctors tailor treatments, or that could help researchers develop more effective drugs. So in neurolo
Large language models are already changing the business of search. But now they’re about to change the practice of medicine. Harry's guests, Vivek Natarajan and Shek Azizi, are both researchers on the Health AI team at Google, where they're pus
Harry's guests this week are Sri Kosaraju, the CEO of Inscripta, and Richard Fox, a former Inscripta scientist who just rejoined the company as its SVP of Synthetic Biology. In reabsorbing Infinome—the Inscripta spinout Fox described to Harry i
Harry's guest this week, Jen Nwankwo, is the founder and CEO of a drug discovery company in Boston called 1910 Genetics. Her PhD is in pharmacology, which shows through in her practical focus on fixing the drug discovery process to get more and
Tears are a signal of more than just our emotions. The liquid in tears comes from blood plasma, and contains a lot of the same proteins and other biomolecules that circulate in the bloodstream. But what this liquid doesn’t have are a lot of the
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us